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Abstract Introduction. Perimenopause occurs in a woman's life 
between the reproductive period and the onset of aging. Hormo-
nal changes occurring in a woman’s body in the perimenopausal 
lead to symptoms of the climacteric syndrome. Symptoms can 
persist for several years, affecting the quality of life of a woman.  
Aim of the study. The aim of the study was to assess the health of 
women in the perimenopausal period. 
Materials and method. The study group consisted of 200 women. 
The research tools were: a self-developed questionnaire survey to 
assess the characteristics of the study group and "Women's Health 
Questionnaire” (WHQ). The results obtained were analysed sta-
tistically. 
Conclusions. In the perimenopausal period, women experience 
increased vasomotor symptoms and feel physically unattractive. 
Quite often they also indicate problems with sleep, memory, and 
concentration. On the other hand, they are not depressed and do 
not feel anxiety or anxiety. Age, place of residence, education and 
marital status are the determinants of the health aspects of the 
study group. 
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Streszczenie – Wstęp. Okres okołomenopauzalny występuje w 
życiu kobiety pomiędzy okresem reprodukcyjnym, a początkiem 
okresu starzenia się. Zmiany hormonalne zachodzące w organi-
zmie kobiety w okresie okołomenopauzalnym prowadzą do wy-
stąpienia objawów zespołu klimakterycznego. Objawy mogą 
utrzymywać się przez klika lat wywierając wpływ na jakość życia 
kobiety. 
Cel pracy. Celem pracy była ocena zdrowia kobiet w okresie oko-
łomenopauzalnym. 
Materiał i metoda. Badaną grupę stanowiło 200 kobiet.  Narzę-
dziem badawczym był samodzielnie opracowany kwestionariusz 
ankiety do oceny charakterystyki badanej grupy oraz kwestiona-
riusz „Zdrowie kobiet” (Women’s Health Questionnaire- WHQ). 
Uzyskane wyniki badań poddano analizie statystycznej. 
Wnioski. Kobiety w okresie okołomenopauzalnym odczuwają 
wzmożone objawy naczynioruchowe i czują się nieatrakcyjne 
fizycznie. Dość często wskazują również na problemy ze snem, 
kłopoty z pamięcią i koncentracją. Natomiast nie odczuwają ra-
czej nastroju depresyjnego i nie mają poczucia niepokoju i lęku. 
Wiek, miejsce zamieszkania, wykształcenie i stan cywilny warun-
kują poszczególne aspekty zdrowia w grupie badanych kobiet. 
 
Słowa kluczowe - zdrowie, okres okołomenopauzalny, menopau-
za, objawy. 
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I. INTRODUCTION 
 
erimenopause period, also referred to as perimeno-
pause, is found in a woman's life between reproductive 
and early onset [1]. According to the World Health 
Organization (WHO), it is a period of 2 to 8 years before 
the last monthly bleeding and one year after its occurrence. 
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At the beginning of this period, WHO recognizes the oc-
currence of endocrine, biological, or clinical changes asso-
ciated with menopause. Brudkiewicz [2] states that this is a 
natural biological process in which oestrogen production is 
reduced and then completely stopped. As a consequence, 
this leads to an increase in the number of cycles without a 
hypothyroidism, and finally the physiological disappear-
ance of the menstrual period. Hormonal changes occurring 
in the perimenopausal woman lead to symptoms of the cli-
macteric syndrome. Symptoms may persist for several 
years exerting an influence on the quality of a woman's life 
[3]. 
The aim of the study was to assess the health of women 
in perimenopausal period. 
 
II. MATERIALS AND METHODS 
 
The study group consisted of 200 women. The research 
was carried out in Gynaecological clinic of Medical Centre 
Arion Górnik in Łęczna and at the Chodzki Medical Centre 
in Lublin, as well as education institutions in Lublin (kin-
dergartens and schools) from December 2014 to January 
2016. Participation in the research was voluntary and anon-
ymous. 
The research tools were a self-developed questionnaire 
survey to assess the characteristics of the study group as 
well as "Women's Health Questionnaire” (WHQ). Women's 
Health Questionnaire – WHQ – was developed in 1992 by 
M. Hunter [4]. It is used to evaluate 36 symptoms of mood, 
physical ailments, vasomotor and menstrual symptoms, and 
sexual experiences in women after 45 years of age. Depres-
sion (DEP), somatic symptoms (SOM), memory / concen-
tration (MEM), vasomotor symptoms (VAS), anxiety 
(ANX), sexual behaviour (SEX), sleep disorders (SLE), 
menstrual disorders (MEN), attractiveness (ATT). The 
lower the result, the more positive the assessment of a giv-
en dimension is. The Polish adaptation of the WHQ ques-
tionnaire was made by Bielawska-Batorowicz [5]. 
The results obtained were analysed statistically. In the 
first place, descriptive statistics were analysed – mean, me-
dian, standard deviation, kurtosis and skewness. The next 
step was the series of significance tests and one-way analy-
sis of variance (ANOVA). The significance of the results 
was considered at p≤0.05. The IBM SPSS Statistics 23 
statistical package (PS IMAGO) was used for the calcula-
tions.  
In the study group, the highest percentage was found in 
the surveyed people aged 45-50 years (51.8%), urban 
dwellers (76.4%), having higher education (45.5%), mar-
ried (71.9%) and active professionally (90.5%). 
 
III. RESULTS  
 
Table 1 provides descriptive statistics on the health di-
mensions assessed by the WHQ questionnaire for perimen-
opausal women. Mean WHQ values were highest (VAS) - 
0.54, ATT (0.52) and somatic symptoms (SOM) - 0.49. 
Somewhat better studied assessed their health in dimen-
sions: sleep problems (SLE) - 0.46, memory / concentration 
(MEM) - 0.44, menstrual disorders (MEN) - 0.43 and sex-
ual behaviour (SEX) - 0.38. The lowest mean values were 
obtained in WHQ depressive mood (DEP) domains - 0.31 
and anxiety / anxiety (ANX) - 0.29. 
 
Table 1. Descriptive statistics of health dimensions, as-
sessed by the WHQ questionnaire, for women in the peri-
menopausal period 
 
WHQ 
dimensions 
N M Me Min Max SD 
Slan
t 
Kurto-
sis 
DEP 2
0
0
 
0
.3
1
 
0
.2
9
 
0
.0
0
 
1
.0
0
 
0
.2
5
 
0
.6
1
 
-0
.5
7
 
SOM 2
0
0
 
0
.4
9
 
0
.4
3
 
0
.0
0
 
1
.0
0
 
0
.2
6
 
0
.0
2
 
-0
.6
7
 
MEM 2
0
0
 
0
.4
4
 
0
.3
3
 
0
.0
0
 
1
.0
0
 
0
.3
7
 
0
.1
8
 
-1
.3
3
 
VAS 2
0
0
 
0
.5
4
 
0
.5
0
 
0
.0
0
 
1
.0
0
 
0
.4
3
 
-0
.1
4
 
-1
.6
4
 
ANX 2
0
0
 
0
.2
9
 
0
.2
5
 
0
.0
0
 
1
.0
0
 
0
.2
7
 
0
.8
2
 
0
.1
8
 
SEX 1
7
1
 
0
.3
8
 
0
.3
3
 
0
.0
0
 
1
.0
0
 
0
.3
4
 
0
.4
4
 
-0
.9
7
 
SLE 2
0
0
 
0
.4
6
 
0
.3
3
 
0
.0
0
 
1
.0
0
 
0
.3
5
 
0
.0
9
 
-1
.2
3
 
MEN 2
0
0
 
0
.4
3
 
0
.5
0
 
0
.0
0
 
1
.0
0
 
0
.3
0
 
0
.2
5
 
-0
.7
5
 
ATT 2
0
0
 
0
.5
2
 
0
.5
0
 
0
.0
0
 
1
.0
0
 
0
.3
5
 
0
.1
7
 
-0
.9
9
 
 
 
Table 2 shows the interdependence between the individ-
ual dimensions of health and the age of the examined wom-
en. The t-test results show that the mean health scores 
among younger and older women differed statistically only 
in three out of nine WHQ dimensions. Based on the results, 
it was found that women aged 45-50 years had a better as-
sessment of their vasomotor symptoms (M = 0.45) than 
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women aged 51-55 (M = 0.64). Regarding the health di-
mension of sexual behaviour, the younger women also 
scored significantly better (M = 0.33) than those in the old-
er age group (M = 0.44). The last dimension in which sig-
nificant differences were found were sleep problems. In-
deed, their quality of sleep was rated higher by women 
aged 51-55 years (M = 0.51) compared to women aged 45-
50 years (M = 0.41). 
 
Table 2. Correlation between individual health dimensions 
and age of examined women in perimenopause 
 
 
WHQ 
dimensions 
Compared 
groups 
N M SD t p 
DEP 
45-50 y.o. 
10
3 
0.3
0 
0.2
5 
-
0.5
4 
0.59 
51-55 y.o. 96 
0.3
2 
0.2
5 
SOM 
45-50 y.o. 
10
3 
0.4
8 
0.2
6 
-
0.7
0 
0.49 
51-55 y.o. 96 
0.5
1 
0.2
7 
MEM 
45-50 y.o. 
10
3 
0.4
0 
0.3
5 
-
1.6
8 
0.10+ 
51-55 y.o. 96 
0.4
9 
0.3
9 
VAS 
45-50 y.o. 
10
3 
0.4
5 
0.4
3 
-
3.1
7 
0.002*
* 
51-55 y.o. 96 
0.6
4 
0.4
1 
ANX 
45-50 y.o. 
10
3 
0.3
0 
0.2
7 0.3
5 
0.72 
51-55 y.o. 96 
0.2
8 
0.2
8 
SEX 
45-50 y.o. 93 
0.3
3 
0.3
3 
-
1.9
7 
0.05* 
51-55 y.o. 77 
0.4
4 
0.3
6 
SLE 
45-50 y.o. 
10
3 
0.4
1 
0.3
6 
-
2.1
3 
0.04* 
51-55 y.o. 96 
0.5
1 
0.3
5 
MEN 
45-50 y.o. 
10
3 
0.4
6 
0.2
9 1.4
9 
0.14 
51-55 y.o. 96 
0.4
0 
0.3
2 
ATT 45-50 y.o. 
10
3 
0.5
5 
0.3
6 
1.4
9 
0.14 
 
Significance Levels: *** p <0.001; ** p <0.01; * P ≤ 0.05; + sta-
tistical trend 
 
It can be observed that in the perimenopausal women, 
the health assessment for vasomotor symptoms, sexual be-
haviour, and sleep problems aggravates with age. In addi-
tion, the memory / concentration score was higher than the 
assumed significance level (≤0.05), but less than 0.1 (exact-
ly 0.095), which can be interpreted as a statistical trend. 
This means that the result, though statistically insignificant, 
tends toward materiality and could be achieved under the 
influence of other conditions. 
 
Table 3. Interdependence between individual health dimen-
sions and the place of residence of examined women in 
perimenopause 
 
 
WHQ 
dimensions 
Compared 
groups: place of 
living 
N M SD U p 
DEP 
City 152 0.26 0.22 
2920.00 0.05* 
Village 47 0.34 0.23 
SOM 
City 152 0.46 0.26 
3081.00 0.15 
Village 47 0.52 0.26 
MEM 
city 
 
o 
152 0.40 0.35 
3440.00 0.69 
Village 47 0.43 0.40 
VAS 
City 152 0.52 0.43 
3539.00 0.92 
Village 47 0.51 0.43 
ANX 
City 152 0.28 0.27 
3263.500 0.35 
Village 47 0.30 0.27 
SEX 
City 127 0.36 0.35 
2286.50 0.10+ 
Village 43 0.44 0.31 
SLE 
City 152 0.42 0.35 
2988.00 0.08+ 
Village 47 0.51 0.37 
MEN 
City 152 0.42 0.31 
3561.500 0.98 
Village 47 0.41 0.30 
ATT City 152 0.49 0.34 3431.50 0.66 
 
Significance Levels: *** p <0.001; ** p <0.01; * P ≤ 0.05; + - 
statistical trend 
 
Table 3 shows the interdependence between the individ-
ual dimensions of health and the place of residence of the 
women surveyed. The Mann-Whitney U test, which is a 
nonparametric equivalent of the t test, was used to analyse 
the significance of differences between the women living in 
rural and urban areas. The use of the parametric test was 
not possible due to the failure to meet the equality assump-
tion of the groups compared.  
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Table 4. Interdependence between individual dimensions of health and education of perimenopausal women 
 
WHQ di-
mensions 
Education N M SD F p Compared groups 
Difference in 
averages 
P 
DEP 
Primary/technical 24 0.35 0.26 
4.20 0.02* 
Primary/technical- 
secondary 
-0.004 1.00 
Secondary 84 0.36 0.28 
Primary/technical- 
secondary 
0.10 0.27 
Higher 90 0.25 0.20 Secondary - higher 0.10 0.02* 
SOM 
Primary/technical 24 0.57 0.29 
4.52 0.01* 
Primary/technical- 
secondary 
0.04 0.92 
Secondary 84 0.53 0.26 
Primary/technical- 
higher 
0.14 0.12 
Higher 90 0.43 0.24 Secondary - higher 0.10 0.03* 
MEM 
Primary/technical 24 0.54 0.37 
1.18 0.31 
Primary/technical- 
secondary 
0.10 0.56 
Secondary 84 0.44 0.37 
Primary/technical- 
higher 
0.13 0.33 
Higher 90 0.41 0.37 Secondary - higher 0.03 0.94 
VAS 
Primary/technical 24 0.63 0.40 
4.85 0.01** 
Primary/technical- 
secondary 
0.01 1.00 
Secondary 84 0.62 0.42 
Primary/technical- 
higher 
0.19 0.13 
Higher 90 0.43 0.43 Secondary - higher 0.19 0.01* 
ANX 
Primary/technical 24 0.39 0.37 
2.58 0.08 
Primary/technical- 
secondary 
0.08 0.68 
Secondary 84 0.30 0.28 
Primary/technical- 
higher 
0.13 0.26 
Higher 90 0.25 0.22 Secondary - higher 0.05 0.43 
SEX 
Primary/technical 18 0.41 0.31 
5.49 0.01** 
Primary/technical- 
secondary 
-0.06 0.85 
Secondary 69 0.47 0.34 
Primary/technical- 
higher 
0.12 0.42 
Higher 83 0.29 0.33 Secondary - higher 0.18 0.004** 
SLE 
Primary/technical 24 0.60 0.34 
5.51 0.01** 
Primary/technical- 
secondary 
0.09 0.60 
Secondary 84 0.51 0.35 
Primary/technical- 
higher 
0.22 0.02* 
Higher 90 0.37 0.34 Secondary - higher 0.13 0.03* 
MEN 
Primary/technical 24 0.46 0.36 
0.62 0.54 
Primary/technical- 
secondary 
0.01 0.99 
Secondary 84 0.44 0.29 
Primary/technical- 
higher 
0.06 0.85 
Higher 90 0.40 0.30 Secondary - higher 0.04 0.68 
ATT 
Primary/technical 24 0.50 0.33 
1.93 0.15 
Primary/technical- 
secondary 
-0.07 0.74 
Secondary 84 0.57 0.37 
Primary/technical- 
higher 
0.03 0.96 
Higher 90 0.47 0.35 Secondary - higher 0.11 0.16 
 
Significance Levels: *** p <0.001; ** p <0.01; * P ≤ 0.05; + - statistical trend 
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Table 5. Interdependence between individual health dimensions and marital status of examined women in perimenopause 
 
WHQ dimen-
sions 
Marital status N M SD F p Compared groups 
Difference in 
averages 
p 
DEP 
single 23 0.32 0.26 
2.81 0.04* 
Single - married 0.06 0.91 
Married - widow -0.13 0.63 
married 143 0.27 0.23 Widow - divorced 0.05 0.99 
widow 14 0.36 0.22 Married - widow -0.19 0.10+ 
divorced 19 0.27 0.21 
Married - divorced -0.01 1.00 
Widow - divorced 0.18 0.25 
SOM 
single 23 0.49 0.33 
1.45 0.23 
Single - married 0.02 1.00 
Married - widow -0.10 0.78 
married 143 0.48 0.25 Widow - divorced 0.08 0.93 
widow 14 0.50 0.20 Married - widow -0.13 0.20 
divorced 19 0.41 0.29 
Married - divorced 0.06 0.94 
Widow - divorced 0.18 0.16 
MEM 
single 23 0.35 0.39 
1.36 0.26 
Single - married 0.01 1.00 
Married - widow -0.06 0.99 
married 143 0.41 0.36 Widow - divorced -0.18 0.59 
widow 14 0.36 0.22 Married - widow -0.06 0.99 
divorced 19 0.27 0.21 
Married - divorced -0.18 0.28 
Widow - divorced -0.12 0.92 
VAS 
single 23 0.56 0.48 
0.16 0.92 
Single - married 0.04 0.99 
Married - widow -0.01 1.00 
married 143 0.51 0.43 Widow - divorced -0.01 1.00 
widow 14 0.58 0.20 Married - widow -0.05 0.99 
divorced 19 0.57 0.43 
Married - divorced -0.05 0.99 
Widow - divorced -0.01 1.00 
ANX 
single 23 0.30 0.36 
0.66 0.58 
Single - married -0.01 1.00 
Married - widow -0.06 0.99 
married 143 0.29 0.27 Widow - divorced 0.07 0.94 
widow 14 0.25 0.22 Married - widow -0.06 0.97 
divorced 19 0.25 0.20 
Married - divorced 0.07 0.66 
Widow - divorced 0.13 0.64 
SEX 
single 23 0.38 0.40 
0.52 0.67 
Single - married 0.01 1.00 
Married - widow 0.04 1.00 
married 143 0.37 0.34 Widow - divorced -0.11 0.95 
widow 14 0.33 0.30 Married - widow 0.04 0.99 
divorced 19 0.49 0.34 
Married - divorced -0.12 0.78 
Widow - divorced -0.16 0.88 
SLE 
single 23 0.50 0.34 
0.83 0.48 
Single - married 0.08 0.90 
Married - widow -0.05 0.99 
married 143 0.43 0.36 Widow - divorced 0.08 0.96 
widow 14 0.44 0.40 Married - widow -0.13 0.68 
divorced 19 0.45 0.31 
Married - divorced 0.01 1.00 
Widow - divorced 0.13 0.81 
MEN 
single 23 0.47 0.36 
0.59 0.62 
Single - married 0.08 0.87 
Married - widow 0.11 0.77 
married 143 0.42 0.31 Widow - divorced 0.11 0.87 
widow 14 0.32 0.23 Married - widow 0.31 0.99 
divorced 19 0.35 0.28 
Married - divorced 0.03 0.99 
Widow - divorced -0.01 1.00 
ATT 
single 23 0.50 0.32 
0.20 0.89 
Single - married 0.01 1.00 
Married - widow -0.05 0.99 
married 143 0.50 0.35 Widow - divorced 0.05 0.99 
widow 14 0.42 0.49 Married - widow -0.06 0.99 
divorced 19 0.46 0.41 
Married - divorced 0.04 0.99 
Widow - divorced 0.10 0.98 
 
Significance Levels: *** p <0.001; ** p <0.01; * P ≤ 0.05; + - statistical trend 
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The test was only relevant for the depressive mood. It 
appears that women living in rural areas were significantly 
worse at DEP (M = 0.34) than women living in urban areas 
(M = 0.26). It is also worth noting that the results of the 
Significance of Differences in Sexual Behaviour (SEX) and 
Sleep Disorder (SLE) scores are statistically significant. 
Table 4 shows the interdependence between individual 
health dimensions and the education of perimenopausal 
women. It also presents the results of testing the signifi-
cance of differentials in all dimensions of health in sub-
groups of women with different levels of education. One-
way analysis of variance (ANOVA) was used for this pur-
pose. As shown by the F test results, five of the nine dimen-
sions of health have significant differences in the groups: 
DEP, somatic symptoms (SOM), vasomotor symptoms 
(VAS), sexual behaviour (SEX), and sleep problems (SLE). 
To find out which specific groups within education differed 
in terms of a given health domain, Dunnett's post-hoc T3 
test was used to resist the assumption of homogeneity of 
variance. The test showed that women with secondary edu-
cation were significantly more likely to experience depres-
sive mood (M = 0.36) than women with higher education 
(M = 0.25). Similarly, in terms of somatic symptoms, 
women with lower secondary education rated them more 
negatively (M = 0.53) than women with higher education 
(M = 0.43). The same trend was observed in vasomotor 
symptoms. Women with secondary education experienced 
more such symptoms (M = 0.62) than women with higher 
education (M = 0.43). In the case of sexual behaviour, there 
were also significant differences only when comparing 
women to secondary and tertiary education. The first rated 
the sex life worse (M = 0.47) than women with higher edu-
cation (M = 0.29). 
Table 5 shows the interdependence between the individ-
ual health dimensions and the marital status of the exam-
ined women. One-way analysis of variance (ANOVA) fol-
lowed by post-hoc T3 Dunnett test was used to analyse the 
differences between women with different marital status. A 
more general analysis of variance (F) shows that significant 
differences only occurred with depressive mood (DEP). 
However, after detailed analysis of the differences between 
the groups by post-hoc tests, it turned out that the only dif-
ference between the married and the widowed was in sig-
nificance (statistical tendency), as it cannot be considered 
statistically significant. 
In the analysis of the authors’ own research, widows 
were more likely to experience depressive mood (M = 
0.36) than married women (M = 0.27). 
 
IV. DISCUSSION 
 
Ovarian function and associated hormonal deficiency are 
responsible for the clinical manifestations that can be di-
vided into three groups: vasomotor, somatic, and psycho-
logical symptoms [6]. Vasomotor symptoms are primarily 
hot flashes and excessive sweat. Hot flashes are defined as 
the appearance of a sudden heat stroke that includes the 
face, neck, and chest, often accompanied by skin redness. 
The effect of hot flash is a profuse sweating. These symp-
toms often occur during the night and in stressful situations, 
last from a few seconds to a few minutes and can be re-
versed. Hot flashes are often accompanied by cardiac ar-
rhythmias, nausea, and anxiety. Angioedema occurs in 
about 25% of premenopausal women and remains the case 
for 75% of women after the last menstrual bleeding [7,8]. 
Somatic symptoms include mainly pains and dizziness, 
muscle pain, stiffness and arthralgia, limb numbness, hand 
and foot sensitization, dry skin and mucous membrane, 
fatigue, as well as respiratory problems such as dyspnoea 
[9]. 
Among the psychological symptoms were irritability, 
strong emotions, depression, and anxiety. In perimeno-
pause, there are also disturbed concentration, decreased 
intellectual ability, difficulty with remembering, decreased 
motivation to be active. The low self-esteem also contrib-
utes to the loss of physical attractiveness and reproductive 
capacity. As a result of anatomical, physiological, and psy-
chological changes, disorders in the fulfilment of sexual 
needs and functioning in the sphere of intimate life.  
Brukwicka et al. [11] reported the following predominant 
menopausal symptoms: hot flashes, headaches, and insom-
nia. In turn, Janicka [12] states that postmenopausal women 
experience the most severe symptoms such as depression, 
somatic symptoms, memory and attention problems, and 
sexual dysfunction. Perimenopausal women complain about 
menopausal symptoms, menstrual symptoms, and low at-
tractiveness. Jarecka [13] indicates that perimenopausal 
and postmenopausal women experience the highest number 
of menopausal symptoms compared to premenopausal 
women. Postmenopausal women report more symptoms 
such as depression, memory and attention disorders, somat-
ic symptoms, and sexual dysfunction. Perimenopausal 
women, however, are more concerned about the symptoms 
of menopause and the decrease in attractiveness. Lewicka 
et al. [14] found that 62% of women have problems with 
9
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continuity of sleep and 53.5% of women do not get rest 
after rest at night. 
 
Koligat et al. [15] indicate that the most severe climacteric 
symptoms were observed in perimenopausal women. The 
authors found no symptoms of anxiety in 45% of women 
and no depression in 73% of those in perimenopause. The 
analysis of Lewicka et al. [16] shows that perimenopausal 
mood disorders were predominant in women aged 45-50 
and with basic or vocational education. More than half of 
the subjects had mood swings (71.20%), nervousness 
(72.0%), depression (57.50%), fatigue (70.0%) and con-
centration difficulties (56.50%). Kanadys et al. [17] found 
that about 40% of perimenopausal women had moderate 
symptoms of depression. 
Santos et al. [18] report that in the group of perimenopausal 
women they studied, the percentage of severe symptoms 
was low. However, hot flashes, irritability, and sleep disor-
ders have reached a higher intensity in relation to somatic 
symptoms. According to our own research, the age of peri-
menopausal women was associated with a lower level of 
health as regards vasomotor symptoms, sexual behaviour, 
and sleep problems. In addition, women living in rural are-
as and having secondary education were significantly more 
likely to experience depressive mood than women living in 
cities and having higher education. Women with secondary 
education experience more severe somatic, vascular, and 
sexual behaviour problems than women with higher educa-
tion. 
 
V. CONCLUSIONS 
 
 Perimenopausal women experience increased vas-
omotor symptoms and feel physically unattractive. 
Quite often they also indicate problems with sleep, 
memory, and concentration. On the other hand, 
they do not feel depressed mood and do not feel 
anxiety. 
 Age, place of residence, education and marital sta-
tus determined the particular aspects of health in 
the group of women examined. 
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